Arcellx (ACLX)

• Market cap: $6.71B
• 1 day: 0.01%
• 5 days: 0.04%
• 1 month: 0.26%
• 3 months: 73.23%
• 6 months: 29.88%
• Year to date: 81.24%
• 1 year: 94.05%
• 5 years: 583.33%
• 10 years: 583.33%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 209